Compare Avalanche (AVAX) vs Enzyme (MLN) Price & Performance

Avalanche (AVAX) is currently trading at Rp113,481 with a market cap of Rp48.94T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token trades near pivot point resistance at Rp114,894 with key support at Rp112,943. With 61% of the max supply (715.7 million AVAX) in circulation and average hold time of 85 days, the network maintains steady tokenomics.

Overall outlook remains cautious with bearish technical indicators suggesting potential downside to support levels. Key opportunities include network growth potential with 39% supply yet to circulate, while major risks include continued selling pressure and crypto market volatility. Investors should monitor key resistance at Rp116,952 for trend reversal signals.

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.